Medical imager Point Biomedical recaps with $25M
See our story on this San Carlos, Calif., developer of medical-imaging and drug-delivery technology at VentureBeat Life Sciences.
Next Story: Algae bloom: Solazyme inks development deal with Chevron
Previous Story: Medical imager Point Biomedical recaps with $25M
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.